くすりのしおり

Internal
Published: 11/2017

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
ALAGLIO Divided Granules 1.5g
 Active ingredient:
Aminolevulinic acid hydrochloride
 Dosage form:
white granules
 Print on wrapping:
アラグリオ顆粒剤分包1.5g ALAGLIO Divided Granules 1.5g

Effects of this medicine

This medicine is an in vivo diagnostic agent, which is used at the operation of bladder cancer resection and incorporated into the tumor tissues. Under a blue light source, the medicine makes it easier to distinguish between tumor tissues with red light emission and normal tissues with no emission.
It is usually used at the operation of bladder cancer resection under cystoscopic control.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have porphyria, cardiovascular disorder, liver function disorder, renal function disorder.
  • If you are pregnant, possibly pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • In general, for adults, dissolve 20 mg/kg of the active ingredient with water and take it 3 hours (2 to 4 hours) before the insertion of a cystoscope to bladder. Strictly follow the instructions.
  • If you misuse the medicine, tell your doctor.

Precautions while taking this medicine

  • Avoid sunlight as well as intense indoor light for at least 48 hours after taking the medicine, since it may cause photosensitivity (rash or blister on parts of the skin exposed to sunlight, or excessive sunburn, skin pigmentation or itching caused by exposure to sunlight).
  • Avoid taking any food containing St. John's wort (a kind of herb) for 2 weeks after taking the medicine, since photosensitivity (rash or blister on parts of the skin exposed to sunlight, or excessive sunburn, skin pigmentation or itching caused by exposure to sunlight) may occur.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include nausea and vomiting. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • yellowing of the skin and the white of eyes, dark urine, nausea, vomiting, loss of appetite, general malaise, itch [liver function disorder]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

  • Keep out of the reach of children. Store at room temperature (1 to 30℃), away from light and moisture.
  • Discard the remainder. Do not store them.

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z